News

FlavourSpec® feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

FlavourSpec® feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

The Imspex Group’s proprietary gas chromatography-ion mobility spectrometry (GC-IMS) technology was part of a ground-breaking cancer detection study that was recently carried out by a team of researchers from the University of Warwick, Coventry University and the University of Leicester. In this study, the FlavourSpec® headspace analysis device showed that volatile organic compounds (VOCs) in […]

Into the future with breath analysis

Into the future with breath analysis

Human breath contains up to a thousand volatile organic compounds that, when analysed,  can tell a story about a body’s state of health. These chemical compounds reflect the end processes of metabolic pathways. Patterns of compound peaks form ‘signatures’ when breath is analysed into its components and it is these signatures that allow for disease […]

Breath analysis for COVID-19 screening in Vancouver

A rapid and non-invasive test that can identify whether COVID-19 is present or not can make all the difference in giving people peace of mind to attend appointments for existing medical conditions or to get going again with business, education and sporting activities. This is one of the driving factors for the work of Dr […]

GC-IMS for medical and healthcare applications

GC-IMS for medical and healthcare applications

Imspex Diagnostics’ proprietary GC-IMS analytical technology platform has built a legacy of being a versatile, accurate and robust analytical research tool in situations where compound combinations are complex and/ or concentrations are low. Much of this legacy has centred around volatile compounds in industrial and more recently environmental and food production settings. The ultra-highly sensitive […]

Breath analysis to detect COVID-19

Efforts to develop a quick and non-invasive breath test for the presence of COVID-19 are underway in Vancouver, British Columbia. Imspex’s BreathSpec® is one of a battery of tests that are being used by Dr Renelle Myers and her Vancouver Coastal Health team in their work to develop a breath test that identifies the possible […]

Imspex’s patent portfolio grows

Imspex’s patent portfolio grows

Imspex Diagnostics’ patent portfolio recently grew, with news that the European Patent Office has granted the patent “Method for measuring human exhaled air”. This is the platform that is used to screen for disease indications such as bacterial and viral respiratory tract infections, Group B Streptococcus infection, lung cancer and other chronic inflammatory respiratory conditions. […]

BreathSpec® and the fight against AMR

The Imspex Group’s BreathSpec® technology is well-placed to play a leading role in combatting antimicrobial resistance by helping healthcare practitioners to differentiate between bacterial and viral causes of respiratory infection. This would better allow the right antibiotic to be prescribed to the right patient at the right time and in the right dose , thereby […]

BreathSpec® differentiates COVID-19 from other infections

BreathSpec® differentiates COVID-19 from other infections

Findings of a feasibility study into the potential for breath analysis to help doctors to differentiate between COVID-19 and other respiratory conditions were published in The Lancet on 24 October 2020. The Imspex Group’s BreathSpec® instrument showed clusters of breath compounds reflecting the effects of COVID-19’s multi-system nature. Similar clusters were found independently across research […]

IMSPEX completes SMART Cymru project

IMSPEX completes SMART Cymru project

IMSPEX is pleased to have completed a Welsh Government- and ERDF-backed Technical and Commercial Feasibility (TCF) study focused on translating innovative and high-impact medical technology into solutions that can be implemented and scaled to generate health, wellbeing and economic prosperity within Wales. This study contributed to the Welsh Government’s aim of ensuring that resources an […]